This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 16 (VISN 16), part of the U.S. Department of Veterans Affairs, to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for thyroid testing services, with a ceiling value of $165,200.00 and a period of performance through April 30, 2026. Veracyte has provided similar laboratory testing services to the Department of Defense and Veterans Affairs in the past, using...
This firm fixed-price purchase order was awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services, to conduct referral laboratory testing for thyroid genomic expression classifier (GEC) testing. The $202,552.00 contract has a period of performance through September 30, 2024. Veracyte has provided similar genomic testing services to support cancer detection and diagnosis for...
This firm fixed-price purchase order was awarded by the Veterans Health Administration's Veterans Integrated Service Network 17 (VISN 17) to Veracyte, Inc., a for-profit corporation that provides genomic testing services. The $512,000.00 contract will support cancer detection and diagnosis efforts for VISN 17 facilities through August 2027. Veracyte will provide genomic classifier laboratory testing to analyze gene expression patterns in biopsy samples, aiding in the diagnosis and treatment of...
This is a Delivery Order awarded to Veracyte, Inc., a for-profit organization, by the Veterans Integrated Service Network 16 (VISN 16) of the Department of Veterans Affairs. The contract has a ceiling value of $19,392.00 and is for a Thyroid Testing Task Order to be performed in Jackson, MS. The contract is a Firm Fixed Price with Economic Price Adjustment and does not have a set-aside designation. Veracyte previously held an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle with...
This federal contract award to Veracyte, Inc. provides for thyroid tissue testing services to support cancer detection efforts at Department of Veterans Affairs (VA) medical facilities. The firm fixed price contract, valued at $93,648.69, was issued under the VA's Medical Laboratory Testing and Analysis Services (FSS-621-II) schedule contract. It has an ultimate completion date of September 30, 2020. Veracyte, a for-profit organization, has provided similar genomic testing services to the...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 23 (VISN 23) to Veracyte, Inc., a for-profit company that provides genomic testing services. The contract is a Delivery Order valued at $484,428.50 for "FARGO THYROID BIOPSY TESTING" services. The contract is a Firm Fixed Price agreement with no set-aside designation, and it runs through September 30, 2019. Veracyte holds an Indefinite...
This is a $141,132.01 firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for cancer screening tests, with no set-aside designation. Veracyte has also been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle from VISN 23 to provide reference laboratory services, with a potential value of $600,000 through April 2028....
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 16 to Veracyte, Inc., a for-profit corporate entity specializing in advanced genomic testing services for medical diagnostics. The contract, valued at $450,516.00, is for GENOMIC TESTING services and has an ultimate completion date of May 31, 2029. Veracyte, Inc. will provide precision molecular diagnostic laboratory services, including specialized...
This is a firm fixed price delivery order awarded to Veracyte, Inc. under an Indefinite Delivery Indefinite Quantity (IDIQ) contract with the Veterans Health Administration's Veterans Integrated Service Network 23 (VISN 23). The IDIQ has a ceiling value of $70,000 and a period of performance through April 2025. It provides for Veracyte to deliver reference laboratory services, including specialized genomic testing to support cancer detection and diagnosis for VISN 23 hospitals and clinics....
This is a firm fixed price, definitive contract awarded by the Veterans Integrated Service Network 16 of the U.S. Department of Veterans Affairs to Veracyte, Inc. for laboratory sample testing services. The contract has a ceiling value of $342,256.60 and a period of performance through December 31, 2025. Veracyte, Inc., a for-profit corporation, will provide genomic testing services to support cancer detection and diagnosis efforts, as well as differentiation of idiopathic pulmonary fibrosis, at...